FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Warner Greene

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner Greene; Jay A Levy; Joel Palefsky
HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.
Jonathan K L Chan; Warner Greene
NF-κB/Rel: agonist and antagonist roles in HIV-1 latency.
Mario L Santiago; Diana S Smith; Bradley S Barrett; Mauricio Montano; Robert L Benitez; Roberta Pelanda; Kim J Hasenkrug; Warner Greene
Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Warner Greene (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner Greene; Jay A Levy; Joel Palefsky
HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.
Virology 2011;409(2):211-22.
2011: Jonathan K L Chan; Warner Greene
NF-κB/Rel: agonist and antagonist roles in HIV-1 latency.
Current opinion in HIV and AIDS 2011;6(1):12-8.
2011: Mario L Santiago; Diana S Smith; Bradley S Barrett; Mauricio Montano; Robert L Benitez; Roberta Pelanda; Kim J Hasenkrug; Warner Greene
Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
Journal of virology 2011;85(1):189-99.
2011: Marielle Cavrois; Jason Neidleman; Nicole Galloway; Cynthia A Derdeyn; Eric Hunter; Warner Greene
Measuring HIV fusion mediated by envelopes from primary viral isolates.
Methods (San Diego, Calif.) 2011;53(1):34-8.
2010: Gilad Doitsh; Marielle Cavrois; Kara G Lassen; Orlando Zepeda; Zhiyuan Yang; Mario L Santiago; Andrew M Hebbeler; Warner Greene
Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.
Cell 2010;143(5):789-801.
2010: Silke Wissing; Nicole L K Galloway; Warner Greene
HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.
Molecular aspects of medicine 2010;31(5):383-97.
2010: Kara G Lassen; Silke Wissing; Michael A Lobritz; Mario Santiago; Warner Greene
Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.
The Journal of biological chemistry 2010;285(38):29326-35.
2010: Mario L Santiago; Robert L Benitez; Mauricio Montano; Kim J Hasenkrug; Warner Greene
Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(2):1114-23.
2010: Nadia R Roan; Stefanie Sowinski; Jan Münch; Frank Kirchhoff; Warner Greene
Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
The Journal of biological chemistry 2010;285(3):1861-9.
2010: Kyeong-Ae Kim; Maral Yolamanova; Onofrio Zirafi; Nadia R Roan; Ludger Staendker; Wolf-Georg Forssmann; Adam Burgener; Nathalie Dejucq-Rainsford; Beatrice H Hahn; George M Shaw; Warner Greene; Frank Kirchhoff; Jan Münch
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Retrovirology 2010;7():55.
2009: Ya-Lin Chiu; Warner Greene
APOBEC3G: an intracellular centurion.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2009;364(1517):689-703.
2009: Douglas D Richman; David M Margolis; Martin Delaney; Warner Greene; Daria Hazuda; Roger J Pomerantz
The challenge of finding a cure for HIV infection.
Science (New York, N.Y.) 2009;323(5919):1304-7.
2009: Giovanni Abbadessa; Roberto Accolla; Fernando Aiuti; Adriana Albini; Anna Aldovini; Massimo Alfano; Guido Antonelli; Courtenay Bartholomew; Zvi Bentwich; Umberto Bertazzoni; Jay A Berzofsky; Peter Biberfeld; Enzo Boeri; Luigi Buonaguro; Franco M Buonaguro; Michael Bukrinsky; Arsène Burny; Arnaldo Caruso; Sharon Cassol; Prakash Chandra; Luca Ceccherini-Nelli; Luigi Chieco-Bianchi; Mario Clerici; Sandra Colombini-Hatch; Carlo de Giuli Morghen; Andrea De Maria; Anita de Rossi; Manfred Dierich; Riccardo Della-Favera; Antonina Dolei; Daniel Douek; Volker Erfle; Barbara Felber; Simona Fiorentini; Genoveffa Franchini; Jonathan M Gershoni; Frances Gotch; Patrick Green; Warner Greene; William Hall; William Haseltine; Stephens Jacobson; Lars O Kallings; Vaniambadi S Kalyanaraman; Hermann Katinger; Kamel Khalili; George Klein; Eva Klein; Mary Klotman; Paul Klotman; Moshe Kotler; Reinhard Kurth; Alain Lafeuillade; Michelangelo La Placa; Jonathan Lewis; Flavia Lillo; Julianna Lisziewicz; Anita Lomonico; Lucia Lopalco; Franco Lori; Paolo Lusso; Beatrice Macchi; Michael Malim; Leonid Margolis; Phillip D Markham; Myra McClure; Nancy Miller; Maria C Mingari; Lorenzo Moretta; Douglas M Noonan; Steve O'Brien; Takashi Okamoto; Ranajit Pal; Peter Palese; Amos Panet; Giuseppe Pantaleo; George Pavlakis; Mauro Pistello; Stanley Plotkin; Guido Poli; Roger Pomerantz; Antonia Radaelli; Marjorie Robertguroff; Mario Roederer; Mangalasseril G Sarngadharan; Dominique Schols; Paola Secchiero; Gene Shearer; Antonio Siccardi; Mario Stevenson; Jan Svoboda; Jim Tartaglia; Giuseppe Torelli; Maria Lina Tornesello; Erwin Tschachler; Mauro Vaccarezza; Angelika Vallbracht; Jan van Lunzen; Oliviero Varnier; Elisa Vicenzi; Harald von Melchner; Isaac Witz; Daniel Zagury; Jean-Francois Zagury; giorgio zauli; Donato Zipeto
Unsung hero Robert C. Gallo.
Science (New York, N.Y.) 2009;323(5911):206-7.
2009: Nico Michel; Christine Goffinet; Kerstin Ganter; Ina Allespach; Vineet N KewalRamani; Mohammed Saifuddin; Dan R Littman; Warner Greene; Mark A Goldsmith; Oliver T Keppler
Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.
Retrovirology 2009;6():2.
2009: Rebecca LaRue; Valgerdur Andrésdóttir; yannick blanchard; Silvestro G Conticello; David Derse; Michael Emerman; Warner Greene; Stefán R Jónsson; Nathaniel R Landau; Martin Löchelt; Harmit Malik; Michael H Malim; Carsten Münk; Stephen J O'Brien; Vinay Pathak; Klaus Strebel; Simon Wain-Hobson; XIAOFANG YU; Naoya Yuhki; Reuben S Harris
Guidelines for naming nonprimate APOBEC3 genes and proteins.
Journal of virology 2009;83(2):494-7.
2009: Nadia R Roan; Jan Münch; Nathalie Arhel; Walther Mothes; Jason Neidleman; Akiko Kobayashi; Karen Smith-McCune; Frank Kirchhoff; Warner Greene
The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
Journal of virology 2009;83(1):73-80.
2008: Warner Greene; zeger debyser; Yasuhiro Ikeda; Eric O Freed; Edward Stephens; Wes Yonemoto; Robert W Buckheit; José A Esté; Tomas Cihlar
Novel targets for HIV therapy.
Antiviral research 2008;80(3):251-65.
2008: Mario L Santiago; Mauricio Montano; Robert Benitez; Ronald J Messer; Wes Yonemoto; Bruce Chesebro; Kim J Hasenkrug; Warner Greene
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Science (New York, N.Y.) 2008;321(5894):1343-6.
2008: Anthony Fauci; Margaret I Johnston; Carl W Dieffenbach; Dennis R Burton; Scott M Hammer; James A Hoxie; Malcolm Martin; Julie Overbaugh; David Ian Watkins; Adel Mahmoud; Warner Greene
HIV vaccine research: the way forward.
Science (New York, N.Y.) 2008;321(5888):530-2.
2008: Marielle Cavrois; Jason Neidleman; Warner Greene
The achilles heel of the trojan horse model of HIV-1 trans-infection.
PLoS pathogens 2008;4(6):e1000051.
2008: Hye-Sook Kwon; Michael M Brent; Ruth Getachew; Prerana Jayakumar; Lin Feng Chen; Martina Schnolzer; Michael W McBurney; Ronen Marmorstein; Warner Greene; Melanie Ott
Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation.
Cell host & microbe 2008;3(3):158-67.
2008: Ya-Lin Chiu; Warner Greene
The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
Annual review of immunology 2008;26():317-53.
2007: Nadia R Roan; Warner Greene
A seminal finding for understanding HIV transmission.
Cell 2007;131(6):1044-6.
2007: Warner Greene
A history of AIDS: looking back to see ahead.
European journal of immunology 2007;37 Suppl 1():S94-102.
2007: Samuel Williams; Warner Greene
Regulation of HIV-1 latency by T-cell activation.
Cytokine 2007;39(1):63-74.
2007: Samuel Williams; Hakju Kwon; Lin Feng Chen; Warner Greene
Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.
Journal of virology 2007;81(11):6043-56.
2007: Philip Ellery; Emma Tippett; Ya-Lin Chiu; Geza Paukovics; paul cameron; Ajantha Solomon; Sharon R Lewin; Paul R Gorry; Anthony Jaworowski; Warner Greene; Secondo Sonza; Suzanne M Crowe
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(10):6581-9.
2007: Kim Stopak; Ya-Lin Chiu; Jerry Kropp; Robert M Grant; Warner Greene
Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.
The Journal of biological chemistry 2007;282(6):3539-46.
2007: Vanessa B Soros; Warner Greene
APOBEC3G and HIV-1: strike and counterstrike.
Current HIV/AIDS reports 2007;4(1):3-9.
2007: Vanessa B Soros; Wes Yonemoto; Warner Greene
Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.
PLoS pathogens 2007;3(2):e15.
2007: Christine Goffinet; Nico Michel; Ina Allespach; Hanna-Mari Tervo; Volker Hermann; Hans-Georg Kräusslich; Warner Greene; Oliver T Keppler
Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.
Retrovirology 2007;4():53.
2007: Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; Warner Greene
In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions.
PLoS pathogens 2007;3(1):e4.
2006: Sunil Ahuja; Fernando Aiuti; Ben Berkhout; Peter Biberfeld; Dennis R Burton; Vittorio Colizzi; Steven G Deeks; Ronald C Desrosiers; Manfred P Dierich; Robert W Doms; Michael Emerman; Robert C Gallo; Marc Girard; Warner Greene; James A Hoxie; Eric Hunter; George Klein; Bette Korber; Daniel R Kuritzkes; Michael M Lederman; Michael H Malim; Preston A Marx; Joseph M McCune; Andrew McMichael; Christopher J Miller; Veronica Miller; Luc Montagnier; David C Montefiori; John P Moore; Douglas F Nixon; Julie Overbaugh; C. David Pauza; Douglas D Richman; Michael S Saag; Quentin Sattentau; Robert T Schooley; Robin Shattock; George M Shaw; Mario Stevenson; Alexandra Trkola; Mark A Wainberg; Robin A Weiss; Steven Wolinsky; Jerome A Zack
A plea for justice for jailed medical workers.
Science (New York, N.Y.) 2006;314(5801):924-5.
2006: Erik S Zimmerman; Michael P Sherman; Jana Blackett; Jason Neidleman; Christophe Kreis; Pamela Mundt; Samuel Williams; Maria Warmerdam; James Kahn; Frederick Hecht; Robert M Grant; Carlos M C De Noronha; Andrew S Weyrich; Warner Greene; Vicente Planelles
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
Journal of virology 2006;80(21):10407-18.
2006: Ya-Lin Chiu; Halina Ewa Witkowska; Steven C Hall; Mario Santiago; Vanessa B Soros; Cécile Esnault; Thierry Heidmann; Warner Greene
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(42):15588-93.
2006: Alison M O'Mahony; Jacob Raber; Mauricio Montano; Erik Foehr; V K M Han; Shao-ming Lu; Hakju Kwon; Anthony LeFevour; Shikha Chakraborty-Sett; Warner Greene
NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity.
Molecular and cellular biology 2006;26(19):7283-98.
2006: William Crowley; John Courtney; Larry Jameson; Herbert Pardes; Jay Moskowitz; Eugene P Orringer; Arthur H Rubenstein; Alastair Wood; Richard Rettig; Dennis Ausiello; David Brenner; Francis Collins; Jack Elias; Warner Greene; Ralph Horowitz; Larry Jameson; Elliott Kieff; Craig Thompson; Judith L Swain
The Clinical Research Forum and Association of American Physicians disagree with criticism of the NIH Roadmap.
The Journal of clinical investigation 2006;116(8):2058-9.
2006: Bysani Chandrasekar; Srinivas Mummidi; Lenin Mahimainathan; Devang N Patel; Steven Bailey; Syed Z Imam; Warner Greene; Anthony Valente
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin.
The Journal of biological chemistry 2006;281(22):15099-109.
2006: Vanessa B Soros; Warner Greene
APOBEC3G and HIV-1: strike and counterstrike.
Current infectious disease reports 2006;8(4):317-23.
2006: Ya-Lin Chiu; Warner Greene
Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
Trends in immunology 2006;27(6):291-7.
2006: Jason F Kreisberg; Wes Yonemoto; Warner Greene
Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.
The Journal of experimental medicine 2006;203(4):865-70.
2006: Ya-Lin Chiu; Warner Greene
APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.
The Journal of biological chemistry 2006;281(13):8309-12.
2006: Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; David Fenard; Christian Callebaut; Warner Greene
Human immunodeficiency virus fusion to dendritic cells declines as cells mature.
Journal of virology 2006;80(4):1992-9.
2006: Samuel Williams; Lin Feng Chen; Hakju Kwon; Carmen M Ruiz-Jarabo; Eric Verdin; Warner Greene
NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
The EMBO journal 2006;25(1):139-49.
2005: David Fenard; Wes Yonemoto; Carlos M C De Noronha; Marielle Cavrois; Samuel Williams; Warner Greene
Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):6050-7.
2005: Hakju Kwon; Louise Ogle; Bobby Benitez; Jan Bohuslav; Mauricio Montano; Dean W Felsher; Warner Greene
Lethal cutaneous disease in transgenic mice conditionally expressing type I human T cell leukemia virus Tax.
The Journal of biological chemistry 2005;280(42):35713-22.
2005: Lin Feng Chen; Samuel Williams; Yajun Mu; Hiroyasu Nakano; James M Duerr; Leonard Buckbinder; Warner Greene
NF-kappaB RelA phosphorylation regulates RelA acetylation.
Molecular and cellular biology 2005;25(18):7966-75.
2005: Lin Feng Chen; Warner Greene
Assessing acetylation of NF-kappaB.
Methods (San Diego, Calif.) 2005;36(4):368-75.
2005: Ya-Lin Chiu; Vanessa B Soros; Jason F Kreisberg; Kim Stopak; Wes Yonemoto; Warner Greene
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Nature 2005;435(7038):108-14.
2005: Samuel Williams; Warner Greene
Host factors regulating post-integration latency of HIV.
Trends in microbiology 2005;13(4):137-9.
2005: Kim Stopak; Warner Greene
Protecting APOBEC3G: a potential new target for HIV drug discovery.
Current opinion in investigational drugs (London, England : 2000) 2005;6(2):141-7.
2005: Oliver T Keppler; Ina Allespach; Lismarie Schüller; David Fenard; Warner Greene; Oliver T Fackler
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef.
Journal of virology 2005;79(3):1655-65.
2005: Akihito Yonezawa; Marielle Cavrois; Warner Greene
Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
Journal of virology 2005;79(2):918-26.
2004: Marielle Cavrois; Jason Neidleman; Wes Yonemoto; David Fenard; Warner Greene
HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.
Virology 2004;328(1):36-44.
2004: Samuel Williams; Lin Feng Chen; Hakju Kwon; David Fenard; Dwayne Bisgrove; Eric Verdin; Warner Greene
Prostratin antagonizes HIV latency by activating NF-kappaB.
The Journal of biological chemistry 2004;279(40):42008-17.
2004: Warner Greene
The brightening future of HIV therapeutics.
Nature immunology 2004;5(9):867-71.
2004: Warner Greene
Redistricting the retroviral restriction factors.
Nature medicine 2004;10(8):778-80.
2004: Jan Bohuslav; Lin Feng Chen; Hakju Kwon; Yajun Mu; Warner Greene
p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.
The Journal of biological chemistry 2004;279(25):26115-25.
2004: Lin Feng Chen; Warner Greene
Shaping the nuclear action of NF-kappaB.
Nature reviews. Molecular cell biology 2004;5(5):392-401.
2004: Alison M O'Mahony; Mauricio Montano; Katrien Van Beneden; Lin Feng Chen; Warner Greene
Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
The Journal of biological chemistry 2004;279(18):18137-45.
2004: Evelyne Schaeffer; Vanessa B Soros; Warner Greene
Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.
Journal of virology 2004;78(3):1375-83.
2004: Warner Greene; Lin Feng Chen
Regulation of NF-kappaB action by reversible acetylation.
Novartis Foundation symposium 2004;259():208-17; discussion 218-25.
2004: Marielle Cavrois; Jason Neidleman; Martin Bigos; Warner Greene
Fluorescence resonance energy transfer-based HIV-1 virion fusion assay.
Methods in molecular biology (Clifton, N.J.) 2004;263():333-44.
2004: Warner Greene
How resting T cells deMURR HIV infection.
Nature immunology 2004;5(1):18-9.
2003: Kerstin Zander; Michael P Sherman; Uwe Tessmer; Karsten Bruns; Victor Wray; Alexander T Prechtel; Evelyn Schubert; Peter Henklein; Jeremy Luban; Jason Neidleman; Warner Greene; Ulrich Schubert
Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression.
The Journal of biological chemistry 2003;278(44):43202-13.
2003: Kim Stopak; Carlos M C De Noronha; Wes Yonemoto; Warner Greene
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Molecular cell 2003;12(3):591-601.
2003: Lin Feng Chen; Warner Greene
Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation.
Journal of molecular medicine (Berlin, Germany) 2003;81(9):549-57.
2003: Michael P Sherman; Carlos M C De Noronha; Lauren A Eckstein; Jason Hataye; Pamela Mundt; Samuel Williams; Jason Neidleman; Mark A Goldsmith; Warner Greene
Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages.
Journal of virology 2003;77(13):7582-9.
2003: Cheryl A Stoddart; Romas Geleziunas; Sharon Ferrell; Valerie Linquist-Stepps; Mary E Moreno; Christopher Bare; Weiduan Xu; Wes Yonemoto; Patricia A Bresnahan; Joseph M McCune; Warner Greene
Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis.
Journal of virology 2003;77(3):2124-33.
2002: Lin Feng Chen; Yajun Mu; Warner Greene
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.
The EMBO journal 2002;21(23):6539-48.
2002: Marielle Cavrois; Carlos M C De Noronha; Warner Greene
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.
Nature biotechnology 2002;20(11):1151-4.
2002: Michael P Sherman; Ulrich Schubert; Samuel Williams; Carlos M C De Noronha; Jason F Kreisberg; Peter Henklein; Warner Greene
HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis.
Virology 2002;302(1):95-105.
2002: Michael P Sherman; Carlos M C De Noronha; Samuel Williams; Warner Greene
Insights into the biology of HIV-1 viral protein R.
DNA and cell biology 2002;21(9):679-88.
2002: Warner Greene; B Matija Peterlin
Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy.
Nature medicine 2002;8(7):673-80.
2002: Michael P Sherman; Warner Greene
Slipping through the door: HIV entry into the nucleus.
Microbes and infection / Institut Pasteur 2002;4(1):67-73.
2001: DA Eckstein; Michael P Sherman; ML Penn; Peggy S Chin; Carlos M C De Noronha; Warner Greene; Mark A Goldsmith
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells.
The Journal of experimental medicine 2001;194(10):1407-19.
2001: Carlos M C De Noronha; Michael P Sherman; H W Lin; Marielle Cavrois; Robert D. Moir; R D Goldman; Warner Greene
Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr.
Science (New York, N.Y.) 2001;294(5544):1105-8.
2001: Wolfgang Fischle; Eric Verdin; Warner Greene
Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Science (New York, N.Y.) 2001;293(5535):1653-7.
2001: Romas Geleziunas; Weiduan Xu; Kohsuke Takeda; H Ichijo; Warner Greene
HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell.
Nature 2001;410(6830):834-8.
2001: E Schaeffer; Romas Geleziunas; Warner Greene
Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
Journal of virology 2001;75(6):2993-3000.
2001: Michael P Sherman; Carlos M C De Noronha; M I Heusch; S Greene; Warner Greene
Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.
Journal of virology 2001;75(3):1522-32.
2000: Erik Foehr; Jan Bohuslav; Lin Feng Chen; C DeNoronha; Romas Geleziunas; Xin Lin; Alison M O'Mahony; Warner Greene
The NF-kappa B-inducing kinase induces PC12 cell differentiation and prevents apoptosis.
The Journal of biological chemistry 2000;275(44):34021-4.
2000: Erik Foehr; Xin Lin; Alison M O'Mahony; Romas Geleziunas; Ralph A Bradshaw; Warner Greene
NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(20):7556-63.
2000: Peter Henklein; Karsten Bruns; Michael P Sherman; Uwe Tessmer; Kai Licha; Jeffrey Kopp; Carlos M C De Noronha; Warner Greene; Victor Wray; Ulrich Schubert
Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.
The Journal of biological chemistry 2000;275(41):32016-26.
2000: L Lin; G N DeMartino; Warner Greene
Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.
The EMBO journal 2000;19(17):4712-22.
2000: Michael P Sherman; Carlos M C De Noronha; David Pearce; Warner Greene
Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest.
Journal of virology 2000;74(17):8159-65.
2000: Xin Lin; Alison M O'Mahony; Yajun Mu; Romas Geleziunas; Warner Greene
Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta.
Molecular and cellular biology 2000;20(8):2933-40.
2000: Alison M O'Mahony; Xin Lin; Romas Geleziunas; Warner Greene
Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.
Molecular and cellular biology 2000;20(4):1170-8.
1999: M Heusch; L Lin; Romas Geleziunas; Warner Greene
The generation of nfkb2 p52: mechanism and efficiency.
Oncogene 1999;18(46):6201-8.
1999: Patricia A Bresnahan; Wes Yonemoto; Warner Greene
Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(6):2977-81.
1999: Xin Lin; ET Cunningham; Yajun Mu; Romas Geleziunas; Warner Greene
The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.
Immunity 1999;10(2):271-80.
1998: Y Jenkins; M McEntee; Karsten Weis; Warner Greene
Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways.
The Journal of cell biology 1998;143(4):875-85.
1998: Patricia A Bresnahan; Wes Yonemoto; Sharon Ferrell; D Williams-Herman; Romas Geleziunas; Warner Greene
A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor.
Current biology : CB 1998;8(22):1235-8.
1998: Xin Lin; Yajun Mu; ET Cunningham; Kenneth B Marcu; Romas Geleziunas; Warner Greene
Molecular determinants of NF-kappaB-inducing kinase action.
Molecular and cellular biology 1998;18(10):5899-907.
1998: Teri Liegler; Wes Yonemoto; T Elbeik; E Vittinghoff; S P Buchbinder; Warner Greene
Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors.
The Journal of infectious diseases 1998;178(3):669-79.
1998: Romas Geleziunas; Sharon Ferrell; Xin Lin; Yajun Mu; ET Cunningham; M Grant; Margery A Connelly; JE Hambor; Kenneth B Marcu; Warner Greene
Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.
Molecular and cellular biology 1998;18(9):5157-65.
1998: L Lin; G N DeMartino; Warner Greene
Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.
Cell 1998;92(6):819-28.
1997: Kathleen D Liu; Sarah L Gaffen; Mark A Goldsmith; Warner Greene
Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
Current biology : CB 1997;7(11):817-26.
1997: L Ghoda; X Lin; Warner Greene
The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro.
The Journal of biological chemistry 1997;272(34):21281-8.
1997: M Miller; Maria Warmerdam; Sharon Ferrell; R Benitez; Warner Greene
Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
Virology 1997;234(2):215-25.
1997: D M Powell; M C Amaral; J Y Wu; T Maniatis; Warner Greene
HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(3):973-8.
1996: F Tie; N Adya; Warner Greene; C Z Giam
Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat.
Journal of virology 1996;70(12):8368-74.
1996: Romas Geleziunas; M Miller; Warner Greene
Unraveling the function of HIV type 1 Nef.
AIDS research and human retroviruses 1996;12(17):1579-82.
1996: Virginia Smith Shapiro; M N Mollenauer; Warner Greene; Arthur Weiss
c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1.
The Journal of experimental medicine 1996;184(5):1663-9.
1996: Sarah L Gaffen; SY Lai; M Ha; X Liu; L Hennighausen; Warner Greene; Mark A Goldsmith
Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity.
The Journal of biological chemistry 1996;271(35):21381-90.
1996: Kathleen D Liu; Warner Greene; Mark A Goldsmith
The alpha chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding.
Cytokine 1996;8(8):613-21.
1996: Jerome H Kim; R J McLinden; Joseph Mosca; Maryanne Vahey; Warner Greene; Robert R Redfield
Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(4):343-51.
1996: Warner Greene
Denying HIV safe haven.
The New England journal of medicine 1996;334(19):1264-5.
1996: M Miller; Warner Greene
Is the Nef protein of HIV-1 required for pathogenesis?
Trends in microbiology 1996;4(5):171-2; discussion 173.
1996: Daniel K Hsu; S R Hammes; Ichiro Kuwabara; Warner Greene; Fu-Tong Liu
Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3.
The American journal of pathology 1996;148(5):1661-70.
1996: S Sun; J Elwood; Warner Greene
Both amino- and carboxyl-terminal sequences within I kappa B alpha regulate its inducible degradation.
Molecular and cellular biology 1996;16(3):1058-65.
1996: SY Lai; W Xu; Sarah L Gaffen; Kathleen D Liu; Gregory D Longmore; Warner Greene; Mark A Goldsmith
The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):231-5.
1996: C Béraud; Warner Greene
Interaction of HTLV-I Tax with the human proteasome: implications for NF-kappa B induction.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13 Suppl 1():S76-84.
1995: GA Evans; M A Goldsmith; JA Johnston; W Xu; S R Weiler; RA Erwin; O M Zack Howard; R T Abraham; John O'Shea; Warner Greene
Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association.
The Journal of biological chemistry 1995;270(48):28858-63.
1995: Warner Greene
Predicting progression to AIDS.
Annals of internal medicine 1995;123(9):726-7.
1995: Kathleen D Liu; SY Lai; Mark A Goldsmith; Warner Greene
Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction.
The Journal of biological chemistry 1995;270(38):22176-81.
1995: Mark A Goldsmith; SY Lai; W Xu; M C Amaral; E S Kuczek; L J Parent; Gordon B Mills; K L Tarr; Gregory D Longmore; Warner Greene
Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain.
The Journal of biological chemistry 1995;270(37):21729-37.
1995: Sarah L Gaffen; SY Lai; W Xu; F Gouilleux; B Groner; Mark A Goldsmith; Warner Greene
Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(16):7192-6.
1995: Mark A Goldsmith; M T Warmerdam; RE Atchison; M Miller; Warner Greene
Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.
Journal of virology 1995;69(7):4112-21.
1995: Mark A Goldsmith; M C Amaral; Warner Greene
Ligand binding by the IL-2 receptor is modulated by intracellular determinants of the IL-2 receptor beta-chain.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(5):2033-40.
1995: M Miller; M T Warmerdam; K A Page; Mark B Feinberg; Warner Greene
Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry.
Journal of virology 1995;69(1):579-84.
1994: S C Sun; J Elwood; C Béraud; Warner Greene
Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene.
Molecular and cellular biology 1994;14(11):7377-84.
1994: M Miller; Mark B Feinberg; Warner Greene
The HIV-1 nef gene acts as a positive viral infectivity factor.
Trends in microbiology 1994;2(8):294-8.
1994: Mark A Goldsmith; W Xu; M C Amaral; E S Kuczek; Warner Greene
The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements.
The Journal of biological chemistry 1994;269(20):14698-704.
1994: P Williamson; I Merida; Warner Greene; Glen N Gaulton
The membrane proximal segment of the IL-2 receptor beta-chain acidic region is essential for IL2-dependent protein tyrosine kinase activation.
Leukemia 1994;8 Suppl 1():S186-9.
1994: S C Sun; P A Ganchi; C Béraud; Dean W Ballard; Warner Greene
Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(4):1346-50.
1994: C Béraud; S C Sun; P Ganchi; Dean W Ballard; Warner Greene
Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency.
Molecular and cellular biology 1994;14(2):1374-82.
1994: M Miller; M T Warmerdam; I Gaston; Warner Greene; Mark B Feinberg
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
The Journal of experimental medicine 1994;179(1):101-13.
1993: P A Ganchi; S C Sun; Warner Greene; Dean W Ballard
A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization.
Molecular and cellular biology 1993;13(12):7826-35.
1993: B Stein; Albert S Baldwin; D W Ballard; Warner Greene; P Angel; P Herrlich
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
The EMBO journal 1993;12(10):3879-91.
1993: Warner Greene
AIDS and the immune system.
Scientific American 1993;269(3):98-105.
1993: Hal P Bogerd; Warner Greene
Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
Journal of virology 1993;67(5):2496-502.
1993: William Kuziel; G Ju; TA Grdina; Warner Greene
Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3357-65.
1993: S C Sun; P A Ganchi; Dean W Ballard; Warner Greene
NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
Science (New York, N.Y.) 1993;259(5103):1912-5.
1993: I Merida; P Williamson; William Kuziel; Warner Greene; Glen N Gaulton
The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation.
The Journal of biological chemistry 1993;268(9):6765-70.
1993: S R Hammes; Warner Greene
Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function.
Virology 1993;193(1):41-9.
1993: Stefan Doerre; Prakash Sista; S C Sun; Dean W Ballard; Warner Greene
The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(3):1023-7.
1992: P A Ganchi; S C Sun; Warner Greene; Dean W Ballard
I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Molecular biology of the cell 1992;3(12):1339-52.
1992: G B Mills; N Arima; C May; M Hill; R Schmandt; J Li; N G Miyamoto; Warner Greene
Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
International immunology 1992;4(11):1233-43.
1992: K Kelly; P Davis; Hiroaki Mitsuya; S Irving; J Wright; R Grassmann; Bernhard Fleckenstein; Y Wano; Warner Greene; Ulrich Siebenlist
A high proportion of early response genes are constitutively activated in T cells by HTLV-I.
Oncogene 1992;7(8):1463-70.
1992: Mark B Feinberg; Warner Greene
Molecular insights into human immunodeficiency virus type 1 pathogenesis.
Current opinion in immunology 1992;4(4):466-74.
1992: W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; Dean W Ballard; M Hannink; Warner Greene
The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
Journal of virology 1992;66(8):5018-29.
1992: P A Kaufman; J B Weinberg; Warner Greene
Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells.
The Journal of clinical investigation 1992;90(1):121-9.
1992: Naomichi Arima; William Kuziel; TA Grdina; Warner Greene
IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(1):83-91.
1992: I Weichselbraun; J Berger; M Dobrovnik; Hal P Bogerd; Ralph Grassmann; Warner Greene; Joachim Hauber; E Böhnlein
Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance.
Journal of virology 1992;66(7):4540-5.
1992: M R Smith; Warner Greene
Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein.
Virology 1992;187(1):316-20.
1992: Dean W Ballard; E P Dixon; N J Peffer; Hal P Bogerd; Stefan Doerre; B Stein; Warner Greene
The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1875-9.
1991: Naomichi Arima; J A Molitor; M R Smith; J H Kim; Y Daitoku; Warner Greene
Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation.
Journal of virology 1991;65(12):6892-9.
1991: J A Molitor; Dean W Ballard; Warner Greene
Kappa B-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation.
The New biologist 1991;3(10):987-96.
1991: M R Smith; Warner Greene
Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway.
The Journal of clinical investigation 1991;88(3):1038-42.
1991: Hal P Bogerd; G L Huckaby; Yasmath Ahmed; S M Hanly; Warner Greene
The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(13):5704-8.
1991: J H Lee; Y C Li; Stefan Doerre; Prakash Sista; Dean W Ballard; Warner Greene; B R Franza
A member of the set of kappa B binding proteins, HIVEN86A, is a product of the human c-rel proto-oncogene.
Oncogene 1991;6(4):665-7.
1991: A Hémar; S Cereghini; V Cornet; V Blank; Alain Israël; Warner Greene; Alice Dautry-Varsat
Kappa B binding proteins are constitutively expressed in an IL-2 autocrine human T cell line.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(7):2409-16.
1991: M R Smith; Warner Greene
Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia.
The Journal of clinical investigation 1991;87(3):761-6.
1991: Yasmath Ahmed; G M Gilmartin; S M Hanly; Joseph R Nevins; Warner Greene
The HTLV-I Rex response element mediates a novel form of mRNA polyadenylation.
Cell 1991;64(4):727-37.
1991: Warner Greene
The molecular biology of human immunodeficiency virus type 1 infection.
The New England journal of medicine 1991;324(5):308-17.
1991: J H Kim; P A Kaufman; S M Hanly; Laurence Rimsky; Warner Greene
Rex transregulation of human T-cell leukemia virus type II gene expression.
Journal of virology 1991;65(1):405-14.
1991: M R Smith; Warner Greene
Functional analyses of the type I human T-cell leukemia virus tax gene product.
Transactions of the Association of American Physicians 1991;104():78-91.
1990: J A Molitor; W H Walker; Stefan Doerre; Dean W Ballard; Warner Greene
NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(24):10028-32.
1990: Dean W Ballard; W H Walker; Stefan Doerre; Prakash Sista; J A Molitor; E P Dixon; N J Peffer; M Hannink; Warner Greene
The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
Cell 1990;63(4):803-14.
1990: M R Smith; Warner Greene
Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.
Genes & development 1990;4(11):1875-85.
1990: Bryan R Cullen; Warner Greene
Functions of the auxiliary gene products of the human immunodeficiency virus type 1.
Virology 1990;178(1):1-5.
1990: L A Rubin; F Galli; Warner Greene; D L Nelson; G Jay
The molecular basis for the generation of the human soluble interleukin 2 receptor.
Cytokine 1990;2(5):330-6.
1990: Yasmath Ahmed; S M Hanly; Michael H Malim; Bryan R Cullen; Warner Greene
Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action.
Genes & development 1990;4(6):1014-22.
1990: William Kuziel; Warner Greene
Interleukin-2 and the IL-2 receptor: new insights into structure and function.
The Journal of investigative dermatology 1990;94(6 Suppl):27S-32S.
1990: M R Fung; Warner Greene
The human interleukin-2 receptor: insights into subunit structure and growth signal transduction.
Seminars in immunology 1990;2(2):119-28.
1990: G B Mills; C May; M McGill; M Fung; M Baker; R Sutherland; Warner Greene
Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.
The Journal of biological chemistry 1990;265(6):3561-7.
1990: Warner Greene
Regulation of HIV-1 gene expression.
Annual review of immunology 1990;8():453-75.
1989: JOEL POMERANTZ; F Mauxion; M Yoshida; Warner Greene; RANJAN SEN
A second sequence element located 3' to the NF-kappa B-binding site regulates IL-2 receptor-alpha gene induction.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(12):4275-81.
1989: S R Hammes; E P Dixon; Michael H Malim; Bryan R Cullen; Warner Greene
Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(23):9549-53.
1989: M R Smith; Warner Greene
The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(21):8526-30.
1989: Laurence Rimsky; M D Dodon; E P Dixon; Warner Greene
Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator.
Nature 1989;341(6241):453-6.
1989: Dean W Ballard; E Böhnlein; J A Hoffman; Hal P Bogerd; E P Dixon; B R Franza; Warner Greene
Activation of the interleukin-2 receptor alpha gene: regulatory role for DNA-protein interactions flanking the kappa B enhancer.
The New biologist 1989;1(1):83-92.
1989: S M Hanly; Laurence Rimsky; Michael H Malim; J H Kim; Joachim Hauber; M Duc Dodon; S Y Le; jacob valentine maizel; Bryan R Cullen; Warner Greene
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements.
Genes & development 1989;3(10):1534-44.
1989: Bryan R Cullen; Warner Greene
Regulatory pathways governing HIV-1 replication.
Cell 1989;58(3):423-6.
1989: Warner Greene; E Böhnlein; Dean W Ballard
HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises.
Immunology today 1989;10(8):272-8.
1989: E Böhnlein; Dean W Ballard; Hal P Bogerd; N J Peffer; J W Lowenthal; Warner Greene
Induction of interleukin-2 receptor-alpha gene expression is regulated by post-translational activation of kappa B specific DNA binding proteins.
The Journal of biological chemistry 1989;264(15):8475-8.
1989: J W Lowenthal; Dean W Ballard; Hal P Bogerd; E Böhnlein; Warner Greene
Tumor necrosis factor-alpha activation of the IL-2 receptor-alpha gene involves the induction of kappa B-specific DNA binding proteins.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(9):3121-8.
1989: Beatrice Hoyos; Dean W Ballard; E Böhnlein; M Siekevitz; Warner Greene
Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.
Science (New York, N.Y.) 1989;244(4903):457-60.
1989: E Böhnlein; M Siekevitz; Dean W Ballard; J W Lowenthal; Laurence Rimsky; H Bogérd; J Hoffman; Y Wano; B R Franza; Warner Greene
Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins.
Journal of virology 1989;63(4):1578-86.
1989: J W Lowenthal; Dean W Ballard; E Böhnlein; Warner Greene
Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(7):2331-5.
1989: Warner Greene; E Böhnlein; M Siekevitz; Dean W Ballard; B R Franza; J W Lowenthal
Structure and regulation of the human IL-2 receptor.
Advances in experimental medicine and biology 1989;254():55-60.
1989: E Böhnlein; J W Lowenthal; Y Wano; B R Franza; Dean W Ballard; Warner Greene
HIV-1, HTLV-I and the interleukin-2 receptor: insights into transcriptional control.
Haematology and blood transfusion 1989;32():393-401.
1988: Y Wano; Mark B Feinberg; J B Hosking; Hal P Bogerd; Warner Greene
Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9733-7.
1988: M R Fung; G Ju; Warner Greene
Co-internalization of the p55 and p70 subunits of the high-affinity human interleukin 2 receptor. Evidence for a stable ternary receptor complex.
The Journal of experimental medicine 1988;168(5):1923-8.
1988: Laurence Rimsky; Joachim Hauber; M Dukovich; Michael H Malim; A Langlois; Bryan R Cullen; Warner Greene
Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.
Nature 1988;335(6192):738-40.
1988: L Collins; W H Tsien; C Seals; J Hakimi; D Weber; P Bailon; J Hoskings; Warner Greene; V Toome; G Ju
Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(20):7709-13.
1988: Dean W Ballard; E Böhnlein; J W Lowenthal; Y Wano; B R Franza; Warner Greene
HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.
Science (New York, N.Y.) 1988;241(4873):1652-5.
1988: E Böhnlein; J W Lowenthal; M Siekevitz; Dean W Ballard; B R Franza; Warner Greene
The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.
Cell 1988;53(5):827-36.
1988: J W Lowenthal; E Böhnlein; Dean W Ballard; Warner Greene
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4468-72.
1988: B R Cullen; F J Podlaski; N J Peffer; J B Hosking; Warner Greene
Sequence requirements for ligand binding and cell surface expression of the Tac antigen, a human interleukin-2 receptor.
The Journal of biological chemistry 1988;263(10):4900-6.
1988: Warner Greene
Sarcoidosis and interleukin-2 receptors.
The American review of respiratory disease 1988;137(4):757-8.
1988: M Zeitz; Warner Greene; N J Peffer; Stephen P James
Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation.
Gastroenterology 1988;94(3):647-55.
1988: Warner Greene; E Böhnlein; M Siekevitz; B R Franza; J Lowenthal
The human interleukin-2 receptor. Recent studies of structure and regulation.
Annals of the New York Academy of Sciences 1988;546():116-21.
1988: Warner Greene; Y J Wano; M Dukovich
New insights into the structure of high-affinity interleukin-2 receptors.
Recent progress in hormone research 1988;44():141-55.
1988: J H Kehrl; M Dukovich; G Whalen; Paul Katz; Anthony Fauci; Warner Greene
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells.
The Journal of clinical investigation 1988;81(1):200-5.
1987: M Siekevitz; S F Josephs; M Dukovich; N Peffer; F Wong-Staal; Warner Greene
Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
Science (New York, N.Y.) 1987;238(4833):1575-8.
1987: J W Lowenthal; Warner Greene
Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor.
The Journal of experimental medicine 1987;166(4):1156-61.
1987: L A Rubin; G S Hoekzema; David L Nelson; Warner Greene; G Jay
Reconstitution of a functional interleukin 2 receptor in a nonlymphoid cell.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(7):2355-60.
1987: L T Bich-Thuy; M Dukovich; N J Peffer; Anthony Fauci; John Kehrl; Warner Greene
Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(5):1550-6.
1987: Warner Greene
The human interleukin-2 receptor: a molecular and biochemical analysis of structure and function.
Clinical research 1987;35(5):439-50.
1987: Y Wano; T Hattori; M Matsuoka; K Takatsuki; A O Chua; U Gubler; Warner Greene
Interleukin 1 gene expression in adult T cell leukemia.
The Journal of clinical investigation 1987;80(3):911-6.
1987: M Siekevitz; Mark B Feinberg; N Holbrook; F Wong-Staal; Warner Greene
Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(15):5389-93.
1987: M Dukovich; Y Wano; Paul Katz; B R Cullen; John Kehrl; Warner Greene
A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
Nature 1987;327(6122):518-22.
1987: W Holter; C K Goldman; L Casabo; D L Nelson; Warner Greene; Thomas Waldmann
Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(9):2917-22.
1987: Y Wano; B R Cullen; P A Svetlik; N J Peffer; Warner Greene
Reconstitution of high affinity IL-2 receptor expression in a human T-cell line using a retroviral cDNA expression vector.
Molecular biology & medicine 1987;4(2):95-109.
1987: R J Robb; C M Rusk; J Yodoi; Warner Greene
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(7):2002-6.
1987: R J Robb; Warner Greene
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.
The Journal of experimental medicine 1987;165(4):1201-6.
1987: Warner Greene; Warren J Leonard; Y Wano; P B Svetlik; N J Peffer; Joseph Sodroski; C A Rosen; W C Goh; W A Haseltine
Trans-activator gene of HTLV-II: interpretation.
Science (New York, N.Y.) 1987;235(4792):1073.
1987: Warner Greene; Warren J Leonard
Human interleukin 2 receptor (Tac antigen).
Methods in enzymology 1987;150():682-700.
1987: Warner Greene
An overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties.
Cancer investigation 1987;5(4):369-76.
1986: P K Chanda; G F Chen; Y Baine; Warren J Leonard; Warner Greene; T W Chang; N T Chang
Expression of human interleukin-2 receptor cDNA in E. coli.
Biochemical and biophysical research communications 1986;141(2):804-11.
1986: L M Neckers; S Bauer; R C McGlennen; Jane Trepel; K Rao; Warner Greene
Diltiazem inhibits transferrin receptor expression and causes G1 arrest in normal and neoplastic T cells.
Molecular and cellular biology 1986;6(12):4244-50.
1986: Warner Greene; Warren J Leonard; J M Depper; D L Nelson; Thomas Waldmann
The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.
Annals of internal medicine 1986;105(4):560-72.
1986: Warner Greene
Characterization of the human interleukin 2 receptor at the DNA, RNA, and protein level.
Immunobiology 1986;172(3-5):357-64.
1986: Warner Greene; J M Depper; M Krönke; Warren J Leonard
The human interleukin-2 receptor: analysis of structure and function.
Immunological reviews 1986;92():29-48.
1986: M Krönke; E Schlick; Thomas Waldmann; E S Vitetta; Warner Greene
Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
Cancer research 1986;46(7):3295-8.
1986: B F Treiger; Warren J Leonard; P Svetlik; L A Rubin; D L Nelson; Warner Greene
A secreted form of the human interleukin 2 receptor encoded by an "anchor minus" cDNA.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(11):4099-105.
1986: Warner Greene; Warren J Leonard; Y Wano; P B Svetlik; N J Peffer; Joseph Sodroski; C A Rosen; W C Goh; W A Haseltine
Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression.
Science (New York, N.Y.) 1986;232(4752):877-80.
1986: A M Weissman; J B Harford; P B Svetlik; W L Leonard; J M Depper; Thomas Waldmann; Warner Greene; R D Klausner
Only high-affinity receptors for interleukin 2 mediate internalization of ligand.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(5):1463-6.
1986: Thomas Waldmann; S J Korsmeyer; Warner Greene
The arrangement of immunoglobulin, T cell antigen receptor, and interleukin 2 receptor genes in human lymphoid neoplasms.
Symposium on Fundamental Cancer Research 1986;38():63-78.
1986: Warner Greene; Warren J Leonard
The human interleukin-2 receptor.
Annual review of immunology 1986;4():69-95.
1986: Warner Greene; J M Depper; M Krönke; Warren J Leonard
The human interleukin-2 receptor: role in normal T-cell growth and association with HTLV-I-induced T-cell leukemia.
Cold Spring Harbor symposia on quantitative biology 1986;51 Pt 2():731-7.
1986: Warner Greene; Warren J Leonard; J M Depper
Growth of human T lymphocytes: an analysis of interleukin 2 and its cellular receptor.
Progress in hematology 1986;14():283-301.
1985: Warren J Leonard; J M Depper; M Kanehisa; M Krönke; N J Peffer; P B Svetlik; M Sullivan; Warner Greene
Structure of the human interleukin-2 receptor gene.
Science (New York, N.Y.) 1985;230(4726):633-9.
1985: J C Reed; Warner Greene; R G Hoover; P C Nowell
Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(4):2478-82.
1985: Warren J Leonard; M Krönke; N J Peffer; J M Depper; Warner Greene
Interleukin 2 receptor gene expression in normal human T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(18):6281-5.
1985: Warner Greene; J M Depper; G R Crabtree; Stuart Rudikoff; J Pumphrey; R J Robb; M Krönke; P Svetlik; N J Peffer; Thomas Waldmann
Isolation and expression of complementary DNAs encoding the human interleukin 2 receptor.
Cancer research 1985;45(9 Suppl):4563s-4567s.
1985: Thomas Waldmann; Dan Longo; Warren J Leonard; J M Depper; Craig Thompson; M Krönke; C K Goldman; S Sharrow; K Bongiovanni; Warner Greene
Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
Cancer research 1985;45(9 Suppl):4559s-4562s.
1985: H Clifford Lane; J M Depper; Warner Greene; G Whalen; Thomas Waldmann; Anthony Fauci
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.
The New England journal of medicine 1985;313(2):79-84.
1985: Warner Greene; R J Robb; P B Svetlik; C M Rusk; J M Depper; Warren J Leonard
Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells.
The Journal of experimental medicine 1985;162(1):363-8.
1985: Warren J Leonard; T A Donlon; R V Lebo; Warner Greene
Localization of the gene encoding the human interleukin-2 receptor on chromosome 10.
Science (New York, N.Y.) 1985;228(4707):1547-9.
1985: M Krönke; Warren J Leonard; J M Depper; Warner Greene
Deregulation of interleukin-2 receptor gene expression in HTLV-I-induced adult T-cell leukemia.
Science (New York, N.Y.) 1985;228(4704):1215-7.
1985: J Miller; Thomas R Malek; Warren J Leonard; Warner Greene; E M Shevach; R N Germain
Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(6):4212-7.
1985: M Krönke; Warren J Leonard; J M Depper; Warner Greene
Sequential expression of genes involved in human T lymphocyte growth and differentiation.
The Journal of experimental medicine 1985;161(6):1593-8.
1985: J M Depper; Warren J Leonard; Cynthia L Drogula; M Krönke; Thomas Waldmann; Warner Greene
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(12):4230-4.
1985: M Krönke; J M Depper; Warren J Leonard; E S Vitetta; Thomas Waldmann; Warner Greene
Adult T cell leukemia: a potential target for ricin A chain immunotoxins.
Blood 1985;65(6):1416-21.
1985: Warren J Leonard; J M Depper; M Krönke; R J Robb; Thomas Waldmann; Warner Greene
The human receptor for T-cell growth factor. Evidence for variable post-translational processing, phosphorylation, sulfation, and the ability of precursor forms of the receptor to bind T-cell growth factor.
The Journal of biological chemistry 1985;260(3):1872-80.
1985: Warner Greene; J M Depper; M Krönke; Warren J Leonard
The human interleukin-2 receptor.
Journal of cell science. Supplement 1985;3():97-106.
1985: J C Reed; R J Robb; Warner Greene; P C Nowell
Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(1):314-23.
1985: Warner Greene; J M Depper; G R Crabtree; Stuart Rudikoff; J Pumphrey; R J Robb; M Krönke; P Svetlik; N J Peffer; Thomas Waldmann
Molecular cloning of cDNA for the human interleukin-2 receptor.
Haematology and blood transfusion 1985;29():388-95.
1985: Warner Greene; R J Robb
Receptors for T-cell growth factor: structure, function and expression on normal and neoplastic cells.
Contemporary topics in molecular immunology 1985;10():1-34.
1985: J M Depper; Warren J Leonard; Cynthia L Drogula; M Krönke; Thomas Waldmann; Warner Greene
Activators of protein kinase C and 5-azacytidine induce IL-2 receptor expression on human T lymphocytes.
Journal of cellular biochemistry 1985;27(3):267-76.
1984: S J Korsmeyer; Warner Greene; Thomas Waldmann
Cellular origin of hairy cell leukemia: malignant B cells that express receptors for T cell growth factor.
Seminars in oncology 1984;11(4):394-400.
1984: J M Depper; Warren J Leonard; M Krönke; P D Noguchi; R E Cunningham; Thomas Waldmann; Warner Greene
Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(6):3054-61.
1984: Thomas Waldmann; C K Goldman; R J Robb; J M Depper; Warren J Leonard; Susan O Sharrow; K F Bongiovanni; S J Korsmeyer; Warner Greene
Expression of interleukin 2 receptors on activated human B cells.
The Journal of experimental medicine 1984;160(5):1450-66.
1984: R J Robb; Warner Greene; C M Rusk
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.
The Journal of experimental medicine 1984;160(4):1126-46.
1984: J M Depper; Warren J Leonard; M Krönke; Thomas Waldmann; Warner Greene
Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(4):1691-5.
1984: M Krönke; Warren J Leonard; J M Depper; S K Arya; F Wong-Staal; Robert C Gallo; Thomas Waldmann; Warner Greene
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(16):5214-8.
1984: Warner Greene; R J Robb; J M Depper; Warren J Leonard; Cynthia L Drogula; P B Svetlik; F Wong-Staal; Robert C Gallo; Thomas Waldmann
Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):1042-7.
1984: Thomas Waldmann; Warner Greene; P S Sarin; C Saxinger; Douglas W Blayney; William A Blattner; C K Goldman; K Bongiovanni; S Sharrow; J M Depper
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
The Journal of clinical investigation 1984;73(6):1711-8.
1984: S Lipkowitz; Warner Greene; A L Rubin; A Novogrodsky; K H Stenzel
Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(1):31-7.
1984: Thomas Waldmann; C K Goldman; Warren J Leonard; J M Depper; R J Robb; S J Korsmeyer; Warner Greene
Interleukin-2 receptors on activated malignant and normal B-cells.
Current topics in microbiology and immunology 1984;113():96-101.
1984: Thomas Waldmann; Warren J Leonard; J M Depper; M Krönke; C K Goldman; T Oh; Warner Greene
Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Princess Takamatsu symposia 1984;15():259-68.
1983: B H Littman; A V Muchmore; A D Steinberg; Warner Greene
Monoclonal lupus autoantibody secretion by human-human hybridomas. Selection of hybrids by conventional and novel techniques.
The Journal of clinical investigation 1983;72(6):1987-94.
1983: Warren J Leonard; J M Depper; R J Robb; Thomas Waldmann; Warner Greene
Characterization of the human receptor for T-cell growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(22):6957-61.
1983: Z Lando; P Sarin; M Megson; Warner Greene; T A Waldman; Robert C Gallo; S Broder
Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor.
Nature 1983;305(5936):733-6.
1983: R J Robb; Warner Greene
Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.
The Journal of experimental medicine 1983;158(4):1332-7.
1983: J M Depper; Warren J Leonard; R J Robb; Thomas Waldmann; Warner Greene
Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(2):690-6.
1983: Stanley J Korsmeyer; Warner Greene; J Cossman; S M Hsu; J P Jensen; L M Neckers; S L Marshall; A Bakhshi; J M Depper; Warren J Leonard; E S Jaffe; Thomas Waldmann
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(14):4522-6.
1983: G A Koretzky; R P Daniele; Warner Greene; P C Nowell
Evidence for an interleukin-independent pathway for human lymphocyte activation.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(11):3444-7.
1983: J Cossman; L M Neckers; Warren J Leonard; Warner Greene
Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen.
The Journal of experimental medicine 1983;157(3):1064-9.
1983: Warner Greene; J M Depper; Warren J Leonard; T A Fleisher; Thomas Waldmann
Construction of human suppressor T cell hybridomas.
Lymphokine research 1983;2(2):53-60.
1983: R. Michael Blaese; G Tosato; Warner Greene; T A Fleisher; A V Muchmore
The role of cell surface lectin--carbohydrate interactions in cellular recognition, cooperation, and regulation.
The American journal of pediatric hematology/oncology 1983;5(2):199-206.
1982: Warren J Leonard; J M Depper; T Uchiyama; Kendall A Smith; Thomas Waldmann; Warner Greene
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.
Nature 1982;300(5889):267-9.
1982: Warner Greene; T A Fleisher; D L Nelson; Thomas Waldmann
Production of human suppressor T cell hybridomas.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(5):1986-92.
1982: Warner Greene; T A Fleisher; J M Depper; Warren J Leonard; G J Stanton; Thomas Waldmann
Characterization of a soluble suppressor of human B cell function produced by a continuous human suppressor T cell line. II. Evidence for suppression through a direct action of CTC-SISS-B on human B cells.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1120-3.
1982: T A Fleisher; A M Attallah; G Tosato; R M Blaese; Warner Greene
Interferon-mediated inhibition of human polyclonal immunoglobulin synthesis.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1099-103.
1981: Warner Greene; C K Goldman; S T Marshall; T A Fleisher; Thomas Waldmann
Stimulation of immunoglobulin biosynthesis in human B cells by wheat germ agglutinin. I. Evidence that WGA can produce both a positive and negative signal for activation of human lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(2):799-804.
1981: T A Fleisher; Warner Greene; T Uchiyama; C K Goldman; D L Nelson; R M Blaese; Thomas Waldmann
Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line.
The Journal of experimental medicine 1981;154(1):156-67.
1981: T A Fleisher; Warner Greene; R M Blaese; Thomas Waldmann
Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(3):1192-7.
1981: Warner Greene; T A Fleisher; Thomas Waldmann
Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(3):1185-91.
1981: Warner Greene; T A Fleisher; Thomas Waldmann
Suppression of human T and B lymphocyte activation by Agaricus bisporus lectin. I. Suggestive evidence for a surface "suppressor" receptor in human lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(2):580-6.
1980: Warner Greene; Thomas Waldmann
Inhibition of human lymphocyte proliferation by the nonmitogenic lectin wheat germ agglutinin.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2979-87.
1976: C W Parker; Warner Greene; H H MacDonald
Cytochalasin binding in lymphocytes and polymorphonuclear leukocytes.
Experimental cell research 1976;103(1):99-108.
1976: Warner Greene; C M Parker; C W Parker
Cytochalasin sensitive structures and lymphocyte activation.
Experimental cell research 1976;103(1):109-17.
1976: Warner Greene; C M Parker; C W Parker
Colchicine-sensitive structures and lymphocyte activation.
Journal of immunology (Baltimore, Md. : 1950) 1976;117(3):1015-22.
1976: Warner Greene; C M Parker; C W Parker
Opposing effects of mitogenic and nonmitogenic lectins on lymphocyte activation. Evidence that wheat germ agglutinin produces a negative signal.
The Journal of biological chemistry 1976;251(13):4017-25.
1976: Warner Greene; C M Parker; C W Parker
Calcium and lymphocyte activation.
Cellular immunology 1976;25(1):74-89.
1976: J P Atkinson; Warner Greene; T A McNearney; C W Parker
Studies on the stimulation of cAMP metabolism in human lymphocytes by latex polymers.
Experimental cell research 1976;99(2):395-407.
1976: C W Parker; R E Dankner; S F Falkenhein; Warner Greene
Suggestive evidence for both stimulatory and inhibitory domains on human lymphocytes, as indicated by phospholipid turnover studies with wheat germ agglutinin and other lectins.
Immunological communications 1976;5(1-2):13-25.
1975: Warner Greene; C W Parker
A role for cytochalasin-sensitive proteins in the regulation of calcium transport in activated human lymphocytes.
Biochemical and biophysical research communications 1975;65(2):456-63.
1975: T J Sullivan; Warner Greene; C W Parker
Concanavalin A-induced histamine release from normal rat mast cells.
Journal of immunology (Baltimore, Md. : 1950) 1975;115(1):278-82.
1971: D T Peterson; Warner Greene; G M Reaven
Effect of experimental diabetes mellitus on kidney ribosomal protein synthesis.
Diabetes 1971;20(10):649-54.